HealthEquity’s credit outlook raised to positive by Moody’s

Moody's Ratings has affirmed HealthEquity, Inc.'s Corporate Family Rating at Ba3, upgrading its outlook from stable to positive. This revision reflects HealthEquity's improved credit metrics, successful integration of the BenefitWallet acquisition, increased scale, and enhanced free cash flow generation. The company, the largest non-bank custodian of Health Savings Accounts, reported a debt-to-EBITDA of 3.4x and generated approximately $300 million in free cash flow for the period ended April 30, 2025, with strong EBITDA margins. The positive outlook signals strengthened competitive positioning and reduced financial leverage, indicating potential for further rating upgrades contingent on sustained revenue expansion and favorable debt metrics, despite its modest current revenue scale and acquisition-driven growth strategy.

Analysis

Moody's has revised HealthEquity, Inc.'s (HQY) credit outlook to positive from stable, while affirming its Ba3 corporate family rating. This change is directly attributable to the successful integration of the BenefitWallet acquisition, which has enhanced the company's scale, improved free cash flow generation, and reduced financial leverage. The company's credit metrics have strengthened, with a debt-to-EBITDA ratio of 3.4x for the twelve months ending April 30, 2025, and robust free cash flow of approximately $300 million, representing 26% of its debt. These developments solidify HealthEquity's position as the largest non-bank Health Savings Account custodian in the U.S. Despite these strengths, the rating is constrained by a modest revenue scale of approximately $1.2 billion relative to peers and a financial policy that utilizes debt to fund its acquisition-led growth strategy. Moody's anticipates mid to high-single-digit organic revenue growth and sustained free cash flow, with a potential rating upgrade contingent on expanding revenue while maintaining EBITDA margins above 30% and debt-to-EBITDA below 4.0x.

Key Decisions for Investors

• The positive credit outlook from Moody's reduces the perceived risk for both debt and equity holders, signaling growing financial stability and a potential future reduction in the cost of capital.
• Investors should closely monitor HealthEquity's ability to maintain its debt-to-EBITDA ratio below the 4.0x threshold and EBITDA margins above 30%, as these are the key metrics identified by Moody's for a potential credit rating upgrade.
• While the recent acquisition has been successful, the company's reliance on debt-funded M&A for growth remains a principal risk factor; any future acquisitions must be evaluated for their impact on leverage, as a significant increase in debt could jeopardize the positive outlook.